An API firm with a history of J&J funding scores a major loan to advance its portfolio

A Massachusetts-based company that manufactures APIs closed its Series A and B fundraising, with J&J among the list of investors. Now, the company is announcing another $49 million loan to help boost operations.Entrinsic Bioscience — or EBS — expects to use the loan to fund programs for GI, airway and skin diseases. CEO Stephen Gatto called these programs a “blueprint for serial innovation” in a press release.

The company boasts that it was the first to discover patented combinations of small-molecule amino acids that can modulate targeted epithelial transmembrane proteins through cell signaling. Its first commercialized product is enterade advanced oncology formula, a sugar-free medical food that can help manage side effects from chemotherapy, such as nausea, diarrhea and weight maintenance.


Logistic 3PL
Center Biokon

We are in social networks

9.00 to 18.00
+38 (044) 585-11-80
+38 (044) 585-11-81
9 Boryspilska St., Velyka Olexandrovka Village, Boryspilskyi District, 08320, Kyiv Region

© 2021 «BIOKON» All rights reserved.